Understanding biosimilars
What is a biosimilar?
A biosimilar medicine is a highly similar version of an original brand of a biological medicine, brought to market once the patent on the original brand expires.
The reason these medicines are known as biosimilar medicines, and not generic medicines, is because biological medicines are large molecules made from living cells, and so the processes that produce them are naturally variable. This means that no two batches are ever exactly the same – not even from the same manufacturer.
Are biosimilar medicines safe to use?
Biosimilar medicines have been used since 2006 when they were introduced in Europe. Their use has steadily increased over time, and they are available in more than 60 countries around the world.
Biosimilar medicines have been available in Australian since 2010 and have helped to improve life for thousands of Australians with serious illnesses such as cancer, rheumatoid arthritis, inflammatory bowel disease, severe psoriasis, multiple sclerosis and kidney disease.
Will I get the same benefit from a biosimilar medicine?
Since biosimilar medicines have been assessed to be as safe and effective as the original biological brand, they also provide the same health benefits.
Ongoing research on biosimilar medicines continues to find no difference in health outcomes between patients who start or switch to a biosimilar medicine and those who remain on the original brand.
Will a biosimilar medicine be the same quality as the original brand?
Australia has a strong regulatory system that ensures the safety, effectiveness and quality of all medicines.
Biosimilar brands of biological medicines are thoroughly tested to show that they are just as safe and effective as the original biological brand before they are approved for use in Australia.
What are the benefits of choosing a biosimilar medicine?
Choosing a biosimilar medicine means you can expect the same treatment benefits as the original biological medicine, with the same standards of safety, quality and effectiveness.
Biosimilar medicines also offer several important benefits:
More choice: Biosimilars provide additional treatment options, giving patients and healthcare professionals more brands to choose from.
Improved access to treatment: By making biological medicines more affordable for the healthcare system, biosimilars can help more patients access these important treatments.
Lower healthcare costs: Biosimilars introduce competition, helping reduce medicine prices and delivering savings to Australia’s Pharmaceutical Benefits Scheme (PBS).
A more sustainable medicines system: Savings from biosimilar competition help free up healthcare funding for new treatments and other patient needs.
While choosing a biosimilar may not always mean paying less for your own prescription, it helps make medicines more affordable and accessible for all Australians.
Will my medicine look different if I use a biosimilar medicine?
The packaging, brand name, or appearance of the medicine may be different. If your medicine is given using an injection pen or pre-filled syringe, the device may also look or work slightly differently.
These differences do not affect how well the medicine works. Biosimilar medicines must meet the same high standards of safety, quality and effectiveness as the original biological medicine.
If you’re switching to a biosimilar, your doctor, pharmacist or nurse can explain any differences and show you how to use your new medicine correctly.
Switching
Is it safe to switch between brands?
Biosimilars are designed to be highly similar to the original brand of a biological brand in terms of efficacy, safety, and quality.
Switching from an original brand to a biosimilar medicine (or from one brand of a biosimilar to another) is common practice and is considered safe and effective.
Who decides that it is safe to switch?
Substitution between brands is considered by the Pharmaceutical Benefits Advisory Committee (PBAC) and recommended on a case-by-case basis.
- The PBAC is an independent expert committee appointed by the Australian Government. Members include eminent, highly qualified and experienced physicians, health professionals, health economists and consumer representatives. Its decisions are based on evidence about clinical effectiveness, safety and cost-effectiveness.